Local Run Manager CF 139-Variant 2.0 Micro Analysis Module 20072975

GUDID 00816270020378

The Local Run Manager CF 139-Variant 2.0 Micro analysis module is for use with TruSight Cystic Fibrosis 139-Variant Assay when processing 24–36 samples. The assay detects 139 clinically relevant cystic fibrosis disease-causing mutations and variants of the cystic fibrosis transmembrane conductance regulator (CFTR) gene in genomic DNA isolated from human peripheral whole blood specimens. The analysis module performs secondary analysis and report generation from sequencing runs that use TruSight Cystic Fibrosis. For more information on TruSight Cystic Fibrosis.

ILLUMINA, INC.

Cystic fibrosis IVD, kit, multiplex
Primary Device ID00816270020378
NIH Device Record Key610932b9-9bce-431c-a311-da7d2922bbd1
Commercial Distribution StatusIn Commercial Distribution
Brand NameLocal Run Manager CF 139-Variant 2.0 Micro Analysis Module
Version Model Number20072975
Catalog Number20072975
Company DUNS033305264
Company NameILLUMINA, INC.
Device Count1
DM Exemptfalse
Pre-market Exemptfalse
MRI Safety StatusLabeling does not contain MRI Safety Information
Human Cell/Tissue Productfalse
Device Kittrue
Device Combination Productfalse
Single Usefalse
Lot Batchtrue
Serial Numberfalse
Manufacturing Datetrue
Expiration Datefalse
Donation Id Numberfalse
Contains Natural Rubber Latexfalse
Labeled No Natural Rubber Latexfalse
RX Perscriptiontrue
OTC Over-The-Counterfalse

Customer Support Contacts

Phone800-809-4566
Emailtechsupport@illumina.com
Phone800-809-4566
Emailtechsupport@illumina.com
Phone800-809-4566
Emailtechsupport@illumina.com
Phone800-809-4566
Emailtechsupport@illumina.com
Phone800-809-4566
Emailtechsupport@illumina.com
Phone800-809-4566
Emailtechsupport@illumina.com
Phone800-809-4566
Emailtechsupport@illumina.com
Phone800-809-4566
Emailtechsupport@illumina.com
Phone800-809-4566
Emailtechsupport@illumina.com
Phone800-809-4566
Emailtechsupport@illumina.com
Phone800-809-4566
Emailtechsupport@illumina.com
Phone800-809-4566
Emailtechsupport@illumina.com
Phone800-809-4566
Emailtechsupport@illumina.com
Phone800-809-4566
Emailtechsupport@illumina.com
Phone800-809-4566
Emailtechsupport@illumina.com
Phone800-809-4566
Emailtechsupport@illumina.com
Phone800-809-4566
Emailtechsupport@illumina.com
Phone800-809-4566
Emailtechsupport@illumina.com

Device Identifiers

Device Issuing AgencyDevice ID
GS100816270020378 [Primary]

FDA Pre-market Approvals/Notifications & deNovo

FDA Product Code

PFRSystem, Cystic Fibrosis Transmembrane Conductance Regulator Gene, Mutations & Variants Panel Sequencing Detection

Sterilization

Steralize Prior To Usefalse
Device Is Sterilefalse

Device Entry Metadata

Public Version StatusUpdate
Device Record StatusPublished
Public Version Number2
Public Version Date2023-07-13
Device Publish Date2023-06-15

Devices Manufactured by ILLUMINA, INC.

00816270020217 - TruSight™ Oncology Comprehensive 2024-12-17 The TruSight Oncology Comprehensive assay is an enrichment-based targeted next generation sequencing (NGS) in-vitro diagnostic t
00816270020644 - TruSight™ Oncology RNA Control2024-12-17 The TruSight Oncology DNA Control and TruSight Oncology RNA Control are control materials sold separately for use as a quality
00816270020651 - TruSight™ Oncology DNA Control IVD2024-12-17 The TruSight Oncology DNA Control and TruSight Oncology RNA Control are control materials sold separately for use as a quality
00816270020262 - Local Run Manager CF Clinical Sequencing Analysis Module2023-07-13 The Local Run Manager CF Clinical Sequencing analysis module is for use with Illumina MiSeqDx Cystic Fibrosis Clinical Sequencin
00816270020286 - Local Run Manager CF 139 Variant Analysis Module2023-07-13 The Local Run Manager CF 139 Variant analysis module is for use with Illumina MiSeqDx Cystic Fibrosis 139-Variant Assay. The ass
00816270020378 - Local Run Manager CF 139-Variant 2.0 Micro Analysis Module2023-07-13The Local Run Manager CF 139-Variant 2.0 Micro analysis module is for use with TruSight Cystic Fibrosis 139-Variant Assay when processing 24–36 samples. The assay detects 139 clinically relevant cystic fibrosis disease-causing mutations and variants of the cystic fibrosis transmembrane conductance regulator (CFTR) gene in genomic DNA isolated from human peripheral whole blood specimens. The analysis module performs secondary analysis and report generation from sequencing runs that use TruSight Cystic Fibrosis. For more information on TruSight Cystic Fibrosis.
00816270020378 - Local Run Manager CF 139-Variant 2.0 Micro Analysis Module2023-07-13 The Local Run Manager CF 139-Variant 2.0 Micro analysis module is for use with TruSight Cystic Fibrosis 139-Variant Assay when p
00816270020385 - Local Run Manager CF Clinical Seq 2.0 Micro Analysis Module2023-07-13 The Local Run Manager CF Clinical Seq 2.0 Micro analysis module is for use with TruSight Cystic Fibrosis Clinical Sequencing Ass
00816270020392 - Local Run Manager DNA GenerateFASTQ Dx Module for MiSeq™Dx2022-11-15 The Local Run Manager (LRM) DNA GenerateFASTQ Dx Module for MiSeq™Dx is used for sequencing run setup, run monitoring, and pri

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.